JP2016503403A5 - - Google Patents

Download PDF

Info

Publication number
JP2016503403A5
JP2016503403A5 JP2015540765A JP2015540765A JP2016503403A5 JP 2016503403 A5 JP2016503403 A5 JP 2016503403A5 JP 2015540765 A JP2015540765 A JP 2015540765A JP 2015540765 A JP2015540765 A JP 2015540765A JP 2016503403 A5 JP2016503403 A5 JP 2016503403A5
Authority
JP
Japan
Prior art keywords
alkyl
acceptable salt
pharmaceutically acceptable
compound
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015540765A
Other languages
English (en)
Japanese (ja)
Other versions
JP6372666B2 (ja
JP2016503403A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/067674 external-priority patent/WO2014070979A1/en
Publication of JP2016503403A publication Critical patent/JP2016503403A/ja
Publication of JP2016503403A5 publication Critical patent/JP2016503403A5/ja
Application granted granted Critical
Publication of JP6372666B2 publication Critical patent/JP6372666B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015540765A 2012-11-03 2013-10-31 サイトメガロウイルスの阻害剤 Active JP6372666B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261722152P 2012-11-03 2012-11-03
US61/722,152 2012-11-03
PCT/US2013/067674 WO2014070979A1 (en) 2012-11-03 2013-10-31 Inhibitors of cytomegalovirus

Publications (3)

Publication Number Publication Date
JP2016503403A JP2016503403A (ja) 2016-02-04
JP2016503403A5 true JP2016503403A5 (enExample) 2016-12-15
JP6372666B2 JP6372666B2 (ja) 2018-08-15

Family

ID=49620281

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015540765A Active JP6372666B2 (ja) 2012-11-03 2013-10-31 サイトメガロウイルスの阻害剤

Country Status (4)

Country Link
US (1) US9334249B2 (enExample)
EP (1) EP2914592B1 (enExample)
JP (1) JP6372666B2 (enExample)
WO (1) WO2014070979A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20181795T1 (hr) 2014-01-13 2019-01-25 Aurigene Discovery Technologies Limited Biciklički heterociklilni derivati kao inhibitori irak4
IL269536B (en) 2017-03-31 2022-07-01 Aurigene Discovery Tech Ltd Compounds and preparations for the treatment of hematological disorders
PL3704108T3 (pl) 2017-10-31 2024-07-22 Curis, Inc. Inhibitor irak4 w połączeniu z inhibitorem bcl-2 do stosowania w leczeniu nowotworu złośliwego
CN112996789B (zh) 2018-09-12 2025-11-11 诺华股份有限公司 抗病毒吡啶并吡嗪二酮化合物
CN114667285B (zh) 2019-09-26 2025-08-08 诺华股份有限公司 抗病毒吡唑并吡啶酮化合物
CN111763201A (zh) * 2020-03-03 2020-10-13 中国药科大学 苯并噻唑类化合物及医药用途
CN113831301B (zh) * 2020-06-08 2023-06-06 沈阳药科大学 苯并噻唑类衍生物及其用途
CA3187651A1 (en) * 2020-07-31 2022-02-03 Eric Sorscher Cystic fibrosis transmembrane conductance regulator (cftr) modulators, pharmaceutical compositions, and uses thereof
AU2022254933A1 (en) 2021-04-08 2023-11-09 Curis, Inc. Combination therapies for the treatment of cancer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166028A (en) * 1998-12-09 2000-12-26 American Home Products Corporation Diaminopuridine-containing thiourea inhibitors of herpes viruses
EP1144397A3 (en) 1998-12-09 2002-09-11 Wyeth Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
CZ20012063A3 (cs) 1998-12-09 2001-10-17 American Home Products Corporation Thiomočovinové sloučeniny obsahující heterocyklický karboxamid a substituovanou fenylendiaminovou skupinu jako inhibitory herpes virů
NZ512108A (en) * 1998-12-09 2003-09-26 Wyeth Corp Thiourea inhibitors of herpes viruses
DE50204780D1 (de) 2001-04-19 2005-12-08 Bayer Healthcare Ag Arylsulfonamide als antivirale mittel
EP1529046A1 (en) 2002-08-08 2005-05-11 Boehringer Ingelheim Pharmaceuticals Inc. Substituted benzimidazole compounds
EP1957461B1 (en) 2005-11-14 2016-11-02 Genentech, Inc. Bisamide inhibitors of hedgehog signaling
JP5296688B2 (ja) * 2006-09-11 2013-09-25 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 殺虫化合物
US20090069288A1 (en) 2007-07-16 2009-03-12 Breinlinger Eric C Novel therapeutic compounds
US20110294853A1 (en) 2008-09-12 2011-12-01 Benjamin Pelcman Bis Aromatic Compounds for Use in the Treatment of Inflammation
EP2177521A1 (en) 2008-10-14 2010-04-21 Almirall, S.A. New 2-Amidothiadiazole Derivatives
AR077033A1 (es) * 2009-06-11 2011-07-27 Hoffmann La Roche Compuestos inhibidores de las quinasas de janus y su uso en el tratamiento de enfermedades inmunologicas

Similar Documents

Publication Publication Date Title
JP2016503403A5 (enExample)
JP2015536947A5 (enExample)
JP2016505614A5 (enExample)
JP2013544860A5 (enExample)
JP2015537008A5 (enExample)
JP2012144574A5 (enExample)
JP2015512931A5 (enExample)
JP2018135343A5 (enExample)
JP2009263394A5 (enExample)
JP2013542218A5 (enExample)
JP2013510120A5 (enExample)
JP2011518833A5 (enExample)
JP2013544276A5 (enExample)
JP2012092103A5 (enExample)
JP2016503797A5 (enExample)
JP2013537203A5 (enExample)
JP2014526533A5 (enExample)
JP2013534248A5 (enExample)
JP2016515560A5 (enExample)
JP2013532687A5 (enExample)
HRP20171028T1 (hr) Indolski i indazolski spojevi koji aktiviraju ampk
HRP20151370T1 (hr) Derivati benzotiazola kao sredstva protiv raka
JP2016510323A5 (enExample)
JP2011500550A5 (enExample)
JP2011137045A5 (enExample)